An Old Cytokine Against a New Virus?

Abb J , Abb H , Deinhardt F . 1984. Age-related decline of human interferon alpha and interferon gamma production. Blut, 48(5):285–289.

Agrawal A. 2013. Mechanisms and implications of age-associated impaired innate interferon secretion by dendritic cells: a mini-review. Gerontology, 59(5):421–426.

Blanco-Melo D , Nilsson-Payant BE , Liu WC , Uhl S , Hoagland D , Moller R , Jordan TX , Oishi K , Panis M , Sachs D , Wang TT , Schwartz RE , Lim JK , Albrecht RA , tenOever BR . 2020. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell, 181(5):1036.e9–1045.e9.

Broggi A , Ghosh S , Sposito B , Spreafico R , Balzarini F , Lo Cascio A , Clementi N , De Santis M , Mancini N , Granucci F , Zanoni I . 2020. Type III interferons disrupt the lung epithelial barrier upon viral recognition. Science; DOI: 10.1126/science.abc3545.

Channappanavar R , Fett C , Mack M , Ten Eyck PP , Meyerholz DK , Perlman S . 2017. Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection. J Immunol, 198(10):4046–4053.

Chen J , Jiang Q , Xia X , Liu K , Yu Z , Tao W , Gong W , Han JJ . 2020. Individual variation of the SARS-CoV2 receptor ACE2 gene expression and regulation. Preprints, 2020030191, version 1. Available online at: https://www.preprints.org/manuscript/202003.0191/v1 (accessed March 12, 2020 ).

Chu H , Chan JF , Wang Y , Yuen TT , Chai Y , Hou Y , Shuai H , Yang D , Hu B , Huang X , Zhang X , Cai JP , Zhou J , Yuan S , Kok KH , To KK , Chan IH , Zhang AJ , Sit KY , Au WK , Yuen KY . 2020. Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19. Clin Infect Dis. ciaa410; DOI: 10.1093/cid/ciaa410.

Ciancanelli MJ , Abel L , Zhang SY , Casanova JL . 2016. Host genetics of severe influenza: from mouse Mx1 to human IRF7. Curr Opin Immunol, 38:109–120.

Griesbeck M , Ziegler S , Laffont S , Smith N , Chauveau L , Tomezsko P , Sharei A , Kourjian G , Porichis F , Hart M , Palmer CD , Sirignano M , Beisel C , Hildebrandt H , Cenac C , Villani AC , Diefenbach TJ , Le Gall S , Schwartz O , Herbeuval JP , Autran B , Guery JC , Chang JJ , Altfeld M . 2015. Sex differences in plasmacytoid dendritic cell levels of IRF5 drive higher IFN-alpha production in women. J Immunol, 195(11):5327–5336.

Hadjadj J , Yatim N , Barnabei L , Corneau A , Boussier J , Pere H , Charbit B , Bondet V , Chenevier-Gobeaux C , Breillat P , et al. 2020. Impaired type I interferon activity and exacerbated inflammatory responses in severe COVID-19 patients. Preprint medRxiv; DOI: 10.1101/2020.04.19.20068015.

Haller O , Weber F . 2007. Pathogenic viruses: smart manipulators of the interferon system. Curr Top Microbiol Immunol, 316:315–334.

Hung IF-N , Lung K-C , Tso EY-K , et al. 2020. Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet, 395(10238):1695–1704.

Jamilloux Y , Henry T , Belot A , Viel S , Fauter M , El Jammal T , Walzer T , François B , Sève P . 2020. Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions. Autoimmun Rev; DOI: 10.1016/j.autrev.2020.102567.

Klein SL , Flanagan KL . 2016. Sex differences in immune responses. Nat Rev Immunol, 16(10):626–638.

Kopecky-Bromberg SA , Martinez-Sobrido L , Frieman M , Baric RA , Palese P . 2007. Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J Virol, 81(2):548–557.

Lokugamage K , Hage A , Schindewolf C , Rajsbaum R , Menachery VD . 2020. SARS-CoV-2 is sensitive to type I interferon pretreatment. Preprint at bioRxiv; DOI: 10.1101/2020.03.07.982264.

Major J , Crotta S , Llorian M , McCabe TM , Gad HH , Hartmann R , Wack A . 2020. Type I and III interferons disrupt lung epithelial repair during recovery from viral infection. Science; DOI: 10.1126/science.abc2061.

Peckham H , de Gruijter NM , Raine C , Radziszewska A , Ciurtin C , Wedderburn LR , Rosser EC , Deakin CT , Webb K . 2020. Sex-bias in COVID-19: a meta-analysis and review of sex differences in disease and immunity. Res Square; DOI: 10.21203/rs.3.rs-23651/v2.

Perlman S , Netland J . 2009. Coronaviruses post-SARS: update on replication and pathogenesis. Nat Rev Microbiol, 7(6):439–450.

Prokunina-Olsson L , Alphonse N , Dickenson RE , Durbin JE , Glenn JS , Hartmann R , Kotenko SV , Lazear HM , O'Brien TR , Odendall C , Onabajo OO , Piontkivska H , Santer DM , Reich NC , Wack A , Zanoni I . 2020. COVID-19 and emerging viral infections: the case for interferon lambda. J Exp Med, 217(5):e20200653.

Sallard E , Lescure FX , Yazdanpanah Y , Mentre F , Peiffer-Smadja N . 2020. Type 1 interferons as a potential treatment against COVID-19. Antiviral Res, 178:104791.

Trouillet-Assant S , Viel S , Gaymard A , Pons S , Richard JC , Perret M , Villard M , Brengel-Pesce K , Lina B , Mezidi M , Bitker L , Belot A , group CHS . 2020. Type I IFN immunoprofiling in COVID-19 patients. J Allergy Clin Immunol; 10.1016/j.jaci.2020.04.029.

Yuan S , Chan C-Y , Chik K-H , Tsang J-L , Liang R , Cao J , Tang K , Cai J-P , Ye Z-W , Yin F , To K .-W, Chu H , Jin D-Y , Hung I-N , Yuen K-Y , Chan JW. 2020. Broad-spectrum host-based antivirals targeting the interferon and lipogenesis pathways as potential treatment options for the pandemic coronavirus disease 2019 (COVID-19). Viruses, 12, 628.

Yuen C-K , Lam J-Y , Wong W-M , Mak L-F , Wang X , Chu H , Cai J-P , Jin D-Y , To KW , et al. 2020. SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists. Emerg Microbes, Infect:1–29; DOI: 10.1080/22221751.2020.1780953.

Ziegler CGK , Allon SJ , Nyquist SK , et al. 2020. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell, 181(5):1016.e19–1035.e19.